Amedisys (AMED) Competitors $95.39 -0.10 (-0.10%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends AMED vs. ADUS, AHCO, LHCG, DVA, CHE, RCM, CRVL, AMN, MD, and CCRNShould you be buying Amedisys stock or one of its competitors? The main competitors of Amedisys include Addus HomeCare (ADUS), AdaptHealth (AHCO), LHC Group (LHCG), DaVita (DVA), Chemed (CHE), R1 RCM (RCM), CorVel (CRVL), AMN Healthcare Services (AMN), Pediatrix Medical Group (MD), and Cross Country Healthcare (CCRN). Amedisys vs. Addus HomeCare AdaptHealth LHC Group DaVita Chemed R1 RCM CorVel AMN Healthcare Services Pediatrix Medical Group Cross Country Healthcare Amedisys (NASDAQ:AMED) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, community ranking, institutional ownership, risk, earnings, media sentiment, dividends and valuation. Do analysts rate AMED or ADUS? Amedisys presently has a consensus price target of $100.67, suggesting a potential upside of 5.53%. Addus HomeCare has a consensus price target of $131.38, suggesting a potential upside of 1.87%. Given Amedisys' higher probable upside, equities research analysts clearly believe Amedisys is more favorable than Addus HomeCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amedisys 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20Addus HomeCare 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.89 Which has more volatility & risk, AMED or ADUS? Amedisys has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Which has stronger earnings & valuation, AMED or ADUS? Addus HomeCare has lower revenue, but higher earnings than Amedisys. Addus HomeCare is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmedisys$2.24B1.40-$9.75M$2.8034.07Addus HomeCare$1.06B2.20$62.52M$4.2230.56 Does the MarketBeat Community favor AMED or ADUS? Amedisys received 178 more outperform votes than Addus HomeCare when rated by MarketBeat users. However, 68.47% of users gave Addus HomeCare an outperform vote while only 58.72% of users gave Amedisys an outperform vote. CompanyUnderperformOutperformAmedisysOutperform Votes49558.72% Underperform Votes34841.28% Addus HomeCareOutperform Votes31768.47% Underperform Votes14631.53% Is AMED or ADUS more profitable? Addus HomeCare has a net margin of 6.18% compared to Amedisys' net margin of 4.02%. Amedisys' return on equity of 12.39% beat Addus HomeCare's return on equity.Company Net Margins Return on Equity Return on Assets Amedisys4.02% 12.39% 6.78% Addus HomeCare 6.18%9.81%7.11% Do institutionals and insiders believe in AMED or ADUS? 94.4% of Amedisys shares are held by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are held by institutional investors. 1.8% of Amedisys shares are held by company insiders. Comparatively, 4.6% of Addus HomeCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer AMED or ADUS? In the previous week, Addus HomeCare had 9 more articles in the media than Amedisys. MarketBeat recorded 11 mentions for Addus HomeCare and 2 mentions for Amedisys. Addus HomeCare's average media sentiment score of 1.02 beat Amedisys' score of 0.64 indicating that Addus HomeCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amedisys 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Addus HomeCare 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAddus HomeCare beats Amedisys on 14 of the 19 factors compared between the two stocks. Ad Investing Daily2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.Click here. Get Amedisys News Delivered to You Automatically Sign up to receive the latest news and ratings for AMED and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMED vs. The Competition Export to ExcelMetricAmedisysHome health care services IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.12B$2.84B$5.04B$8.43BDividend YieldN/A0.37%7.52%4.16%P/E Ratio34.0721.93130.2316.67Price / Sales1.401.171,720.2276.26Price / Cash15.4815.4336.9133.54Price / Book2.783.034.604.98Net Income-$9.75M-$57.02M$114.94M$224.26M7 Day Performance-0.10%-5.00%0.14%1.65%1 Month Performance-0.76%-2.33%10.15%6.92%1 Year Performance3.88%34.13%33.87%26.46% Amedisys Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMEDAmedisys3.8469 of 5 stars$95.39-0.1%$100.67+5.5%+4.0%$3.12B$2.24B34.0719,000Upcoming EarningsADUSAddus HomeCare4.815 of 5 stars$126.27+1.5%$131.38+4.0%+49.1%$2.29B$1.11B29.9234,846Analyst ForecastNews CoveragePositive NewsAHCOAdaptHealth1.7497 of 5 stars$10.50+2.0%$10.70+1.9%+24.0%$1.41B$3.25B-2.0110,700Upcoming EarningsLHCGLHC GroupN/A$169.81+0.5%N/A+0.0%$5.27B$2.22B82.8330,000High Trading VolumeDVADaVita4.6322 of 5 stars$141.59+1.3%$161.80+14.3%+78.2%$11.61B$12.14B15.2770,000Earnings ReportCHEChemed4.9701 of 5 stars$531.68-1.6%$673.50+26.7%-9.5%$8.00B$2.26B26.8715,087Earnings ReportHigh Trading VolumeRCMR1 RCM2.8538 of 5 stars$14.26flat$15.41+8.1%+23.7%$6.02B$2.25B-142.6030,000Upcoming EarningsCRVLCorVel0.692 of 5 stars$302.14+1.5%N/A+51.3%$5.18B$795.31M66.994,870Positive NewsAMNAMN Healthcare Services4.8564 of 5 stars$36.90-2.7%$60.17+63.1%-45.0%$1.40B$3.79B14.253,585Upcoming EarningsMDPediatrix Medical Group1.7767 of 5 stars$15.21+23.5%$10.90-28.3%+53.7%$1.31B$1.99B-5.025,170Earnings ReportAnalyst ForecastNews CoverageHigh Trading VolumeCCRNCross Country Healthcare4.7696 of 5 stars$11.33-0.7%$19.20+69.5%-41.5%$383.07M$2.02B49.2610,831Upcoming EarningsPositive News Related Companies and Tools Related Companies ADUS Competitors AHCO Competitors LHCG Competitors DVA Competitors CHE Competitors RCM Competitors CRVL Competitors AMN Competitors MD Competitors CCRN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AMED) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedisys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedisys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMED Stock Alerts